Position in BIIB
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$1,098,232
+$166,366 QoQ
Shares Held
5,083
0.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#439
of 1,031 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BIIB Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Cannell & Spears LLC holds $208,924,357 across 12 Drug Manufacturers - General names. BIIB ranks #8 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
557,332 | $71,617,162 | |
| 2 | ABBV |
AbbVie Inc.
|
255,977 | $64,414,052 | |
| 3 | JNJ |
Johnson & Johnson
|
169,381 | $43,017,692 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
236,705 | $13,638,942 | |
| 5 | PFE |
Pfizer Inc
|
236,223 | $5,688,249 | |
| 6 | LLY |
ELI LILLY & Co
|
3,814 | $4,574,626 | |
| 7 | AMGN |
Amgen Inc
|
8,507 | $3,080,554 | |
| 8 | BIIB |
Biogen Inc.
This page
|
5,083 | $1,098,232 |
All Filings in BIIB
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,098,232 | 5,083 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $931,866 | 5,083 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $893,853 | 5,079 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $711,466 | 5,079 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $635,485 | 5,060 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $691,863 | 5,056 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $773,010 | 5,055 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $979,861 | 5,055 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,171,850 | 5,055 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $1,138,526 | 5,280 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $1,366,305 | 5,280 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,357,012 | 5,280 | Shares | Sole | 2023-11-21 | |
| 2023-06-30 | $1,504,008 | 5,280 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,467,998 | 5,280 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,462,137 | 5,280 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,409,760 | 5,280 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,076,803 | 5,280 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $1,111,968 | 5,280 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,266,777 | 5,280 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,494,187 | 5,280 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,828,305 | 5,280 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $1,477,080 | 5,280 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $1,292,860 | 5,280 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $1,497,830 | 5,280 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $1,412,664 | 5,280 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $1,670,486 | 5,280 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||